BSP - Biological Signal Processing Ltd. 

BSP developed the HyperQ™ technology a revolutionary technique which enables a unique, non-invasive and very accurate cardiac test. The HyperQ technology, protected by a number of granted patents and patent applications, is based on proprietary signal processing algorithms for the analysis of high-resolution ECG signals, that enable a much more reliable and effective diagnosis of heart disease, than existing non-invasive tests. The first clinical implementation of the technology is the HyperQ Stress System, offering diagnosis of unmatched quality for ischemic heart disease in the stress-test setting. Future implementations include bed-side monitors and home monitoring devices for cardiac patients, holter monitors, and applications for implantable devices.